Ciudadanía y gobiernos abiertos

Las instituciones públicas tienen la obligación de defender a la ciudadanía y apoyar sus demandas. Para ello se precisa un cambio en las relaciones de poder actual, unas instituciones más flexibles, transparentes, abiertas, participativas, que muestren una vocación por la práctica de la accountability y, sobre todo, por la rendición de cuentas periódica. A su vez se precisa eliminar el clientelismo, abrir los debates a todos los niveles y desligar la función pública de la política fortaleciendo unas estructuras abiertas en donde la capacidad y el mérito presida dicha función pública. Solo de este modo se conseguirá un incremento de la confianza de la sociedad civil hacia nuestras institucione

Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers forMultipleMyeloma: AMeta-Analysis of Three Large Cohorts and Functional Characterization

European Union’s Horizon 2020 research and innovation program, N 856620Instituto de Salud Carlos III and FEDER (Madrid, SpainPI17/02256 and PI20/01845), Consejería de Transformación Económica, Industria, Conocimiento y UniversidadesDietmar Hopp Foundation and the German Ministry of Education and Science (BMBF: CLIOMMICS [01ZX1309]National Cancer Institute of the National Institutes of Health under award numbers: R01CA186646, U01CA249955 (EEB)Science and Technology (FCT)—project UIDB/50026/2020UIDP/50026/2020 and by the project NORTE-01-0145-FEDER-000055PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF

Sistema de gestión del talento en una organización desde el prisma de la Prevención de Riesgos Laborales

La Gestión del Talento y la Prevención de Riesgos Laborales son dos de los pilares fundamentales para el desarrollo y crecimiento interno de las organizaciones, los cuales no se ponen en valor de manera conjunta.Este trabajo pretende poner en valor ambas áreas integradas, no por separado, y plasmar la creación de valor que tiene para la empresa que estén fusionadas en una sola.El principal objetivo que tiene este trabajo es dar a conocer la importancia que tiene en los resultados finales de la organización la gestión eficiente de ambas partes. Los beneficios que presenta y las posibilidades de evolucionar que tienen las organizaciones si invierten en estas áreas.Para ello se exponen los conceptos más importantes de forma separada de cada una de las áreas y posteriormente de forma integrada, presentando los beneficios y las ventajas que supone para la empresa.Se abarcan los temas principales sobre los procesos de Gestión del Talento Humano, siendo el desarrollo de Selección de personal, Evaluación del desempeño y Formación. Considerándose los principales y más importantes dentro de una organización. Estos se plantean integrándolos dentro de la Prevención de Riesgos Laborales.Para reflejar y hacer una idea de lo que supone dentro de una organización, se ha realizado una encuesta que contempla factores psicosociales tales como la Carga mental, Autonomía temporal, Contenido del trabajo, Supervisión y participación, Definición de rol, Interés por el trabajador y Relaciones personales.En función de los resultados del cuestionario se plantean una serie de líneas de actuación para un plan de acción a desarrollar por la empresa para mejorar los resultados de las próximas encuestas y evolucionar como organización.Finalmente se plantea un desarrollo sobre los temas principales sobre los procesos de Gestión del Talento Humano, citados anteriormente; cerrando el documento con una serie de conclusiones finales.En adición final, se han incluido los Objetivos de Desarrollo Sostenible que están alineados con el Trabajo Final de Grado. Además, se han expuesto las metas que persiguen cada uno de estos. El motivo por el que se ha considerado añadirlos ha sido por la importancia que suponen para la empresa los ODS a modo de guía o mapa que les permitirá identificar si su impacto social, económico y medioambiental aporta valor a la sociedad. Como consecuencia, fortalecen su imagen y relaciones con los distintos grupos de interés.<br /

Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

Autophagy; Genetic variants; Multiple myelomaAutofagia; Variantes genéticas; Mieloma múltipleAutofàgia; Variants genètiques; Mieloma múltipleMultiple myeloma (MM) arises following malignant proliferation of plasma cells in the bone marrow, that secrete high amounts of specific monoclonal immunoglobulins or light chains, resulting in the massive production of unfolded or misfolded proteins. Autophagy can have a dual role in tumorigenesis, by eliminating these abnormal proteins to avoid cancer development, but also ensuring MM cell survival and promoting resistance to treatments. To date no studies have determined the impact of genetic variation in autophagy-related genes on MM risk. We performed meta-analysis of germline genetic data on 234 autophagy-related genes from three independent study populations including 13,387 subjects of European ancestry (6863 MM patients and 6524 controls) and examined correlations of statistically significant single nucleotide polymorphisms (SNPs; p < 1 × 10−9) with immune responses in whole blood, peripheral blood mononuclear cells (PBMCs), and monocyte-derived macrophages (MDM) from a large population of healthy donors from the Human Functional Genomic Project (HFGP). We identified SNPs in six loci, CD46, IKBKE, PARK2, ULK4, ATG5, and CDKN2A associated with MM risk (p = 4.47 × 10−4−5.79 × 10−14). Mechanistically, we found that the ULK4rs6599175 SNP correlated with circulating concentrations of vitamin D3 (p = 4.0 × 10−4), whereas the IKBKErs17433804 SNP correlated with the number of transitional CD24+CD38+ B cells (p = 4.8 × 10−4) and circulating serum concentrations of Monocyte Chemoattractant Protein (MCP)-2 (p = 3.6 × 10−4). We also found that the CD46rs1142469 SNP correlated with numbers of CD19+ B cells, CD19+CD3− B cells, CD5+IgD− cells, IgM− cells, IgD−IgM− cells, and CD4−CD8− PBMCs (p = 4.9 × 10−4−8.6 × 10−4) and circulating concentrations of interleukin (IL)-20 (p = 0.00082). Finally, we observed that the CDKN2Ars2811710 SNP correlated with levels of CD4+EMCD45RO+CD27− cells (p = 9.3 × 10−4). These results suggest that genetic variants within these six loci influence MM risk through the modulation of specific subsets of immune cells, as well as vitamin D3−, MCP-2−, and IL20-dependent pathways.This work was supported by the European Union’s Horizon 2020 research and innovation program, N° 856620 and by grants from the Instituto de Salud Carlos III and FEDER (Madrid, Spain; PI17/02256 and PI20/01845), Consejería de Transformación Económica, Industria, Conocimiento y Universidades and FEDER (PY20/01282), from the CRIS foundation against cancer, from the Cancer Network of Excellence (RD12/10 Red de Cáncer), from the Dietmar Hopp Foundation and the German Ministry of Education and Science (BMBF: CLIOMMICS [01ZX1309]), and from National Cancer Institute of the National Institutes of Health under award numbers: R01CA186646, U01CA249955 (EEB). This work was also funded d by Portuguese National funds, through the Foundation for Science and Technology (FCT)—project UIDB/50026/2020 and UIDP/50026/2020 and by the project NORTE-01-0145-FEDER-000055, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF)

Polymorphisms within the TNFSF4 and MAPKAPK2 Loci influence the risk of developing invasive aspergillosis: A two-stage case control study in the context of the aspBIOmics consortium

Here, we assessed whether 36 single nucleotide polymorphisms (SNPs) within the TNFSF4 and MAPKAPK2 loci influence the risk of developing invasive aspergillosis (IA). We conducted a two-stage case control study including 911 high-risk patients diagnosed with hematological malignancies that were ascertained through the aspBIOmics consortium. The meta-analysis of the discovery and replication populations revealed that carriers of the TNFSF4rs7526628T/T genotype had a significantly increased risk of developing IA (p = 0.00022). We also found that carriers of the TNFSF4rs7526628T allele showed decreased serum levels of TNFSF14 protein (p = 0.0027), and that their macrophages had a decreased fungicidal activity (p = 0.048). In addition, we observed that each copy of the MAPKAPK2rs12137965G allele increased the risk of IA by 60% (p = 0.0017), whereas each copy of the MAPKAPK2rs17013271T allele was estimated to decrease the risk of developing the disease (p = 0.0029). Mechanistically, we found that carriers of the risk MAPKAPK2rs12137965G allele showed increased numbers of CD38+IgM-IgD- plasmablasts in blood (p = 0.00086), whereas those harboring two copies of the allele had decreased serum concentrations of thymic stromal lymphopoietin (p = 0.00097). Finally, we also found that carriers of the protective MAPKAPK2rs17013271T allele had decreased numbers of CD27-IgM-IgD- B cells (p = 0.00087) and significantly lower numbers of CD14+ and CD14+CD16- cells (p = 0.00018 and 0.00023). Altogether, these results suggest a role of the TNFSF4 and MAPKAPK2 genes in determining IA risk.This study was supported by grants PI20/01845, PI12/02688, and ISCIII-FEDER PI17/02276 from Fondo de Investigaciones Sanitarias (Madrid, Spain), PIM2010EPA-00756 from the ERA-NET PathoGenoMics (0315900A), the Collaborative Research Center/Transregio 124 FungiNet, the Fundacao para a Ciencia e Tecnologia (FCT) (PTDC/SAU-SER/29635/2017, PTDC/MED-GEN/28778/2017, CEECIND/03628/2017, and CEECIND/04058/2018), the European Union's Horizon 2020 research and innovation programme under grant agreement no. 847507, and the "la Caixa" Foundation (ID 100010434) and FCT under the agreement LCF/PR/HP17/52190003)

Predictors of clinically significant quality of life impairment in Parkinson’s disease

COPPADIS Study Group.Quality of life (QOL) plays an important role in independent living in Parkinson’s disease (PD) patients, being crucial to know what factors impact QoL throughout the course of the disease. Here we identified predictors of QoL impairment in PD patients from a Spanish cohort. PD patients recruited from 35 centers of Spain from the COPPADIS cohort from January 2016, to November 2017, were followed up during 2 years. Health-related QoL (HRQoL) and global QoL (GQoL) were assessed with the 39-item Parkinson’s disease Questionnaire (PDQ-39) and the EUROHIS-QOL 8-item index (EUROHIS-QOL8), respectively, at baseline (V0) and at 24 months ± 1 month (V2). Clinically significant QoL impairment was defined as presenting an increase (PDQ-39SI) or decrement (EUROHIS-QOL8) at V2 ≥ 10% of the score at baseline (V0). A comparison with a control group was conducted for GQoL. GQoL did not change significantly in PD patients (N = 507; p = 0.686) or in the control group (N = 119; p = 0.192). The mean PDQ-39SI was significantly increased in PD patients (62.7 ± 8.5 years old; 58.8% males; N = 500) by 21.6% (from 16.7 ± 13 to 20.3 ± 16.4; p < 0.0001) at V2. Ninety-three patients (18.6%) presented a clinically significant HRQoL impairment at V2. To be younger (OR = 0.896; 95% CI 0.829–0.968; p = 0.006), to be a female (OR = 4.181; 95% CI 1.422–12.290; p = 0.009), and to have a greater increase in BDI-II (Beck Depression Inventory-II) (OR = 1.139; 95% CI 1.053–1.231; p = 0.001) and NMSS (Non-Motor Symptoms Scale) (OR = 1.052; 95% CI 1.027–1.113; p < 0.0001) total scores from V0 to V2 were associated with clinically significant HRQoL impairment at the 2-year follow-up (Hosmer–Lemeshow test, p = 0.665; R 2 = 0.655). An increase in ≥5 and ≥10 points of BDI-II and NMSS total score at V2 multiplied the probability of presenting clinically significant HRQoL impairment by 5 (OR = 5.453; 95% CI 1.663–17.876; p = 0.005) and 8 (OR = 8.217; 95% CI, 2.975–22.696; p = 0.002), respectively. In conclusion, age, gender, mood, and non-motor impairment were associated with clinically significant HRQoL impairment after the 2-year follow-up in PD patients.Mir P. has received honoraria from AbbVie, Abbott, Allergan, Bial, Merz, UCB and Zambon and have received grants from the Spanish Ministry of Economy and Competitiveness [PI16/01575] co-founded by ISCIII (Subdirección General de Evaluación y Fomento de la Investigación) and by Fondo Europeo de Desarrollo Regional (FEDER), the Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía [CVI-02526, CTS-7685], the Consejería de Salud y Bienestar Social de la Junta de Andalucía [PI-0437-2012, PI-0471-2013], the Sociedad Andaluza de Neurología, the Jacques and Gloria Gossweiler Foundation, the Fundación Alicia Koplowitz, the Fundación Mutua Madrileña.Peer reviewe

Polymorphisms within autophagy-related genes as susceptibility biomarkers for multiple myeloma: a meta-analysis of three large cohorts and functional characterization

Functional data used in this project have been meticulously catalogued and archived in the BBMRI-NL data infrastructure (https://hfgp.bbmri.nl/, accessed on 12 February 2020) using the MOLGENIS open-source platform for scientific data.Multiple myeloma (MM) arises following malignant proliferation of plasma cells in the bone marrow, that secrete high amounts of specific monoclonal immunoglobulins or light chains, resulting in the massive production of unfolded or misfolded proteins. Autophagy can have a dual role in tumorigenesis, by eliminating these abnormal proteins to avoid cancer development, but also ensuring MM cell survival and promoting resistance to treatments. To date no studies have determined the impact of genetic variation in autophagy-related genes on MM risk. We performed meta-analysis of germline genetic data on 234 autophagy-related genes from three independent study populations including 13,387 subjects of European ancestry (6863 MM patients and 6524 controls) and examined correlations of statistically significant single nucleotide polymorphisms (SNPs; p < 1 × 10−9) with immune responses in whole blood, peripheral blood mononuclear cells (PBMCs), and monocyte-derived macrophages (MDM) from a large population of healthy donors from the Human Functional Genomic Project (HFGP). We identified SNPs in six loci, CD46, IKBKE, PARK2, ULK4, ATG5, and CDKN2A associated with MM risk (p = 4.47 × 10−4−5.79 × 10−14). Mechanistically, we found that the ULK4rs6599175 SNP correlated with circulating concentrations of vitamin D3 (p = 4.0 × 10−4), whereas the IKBKErs17433804 SNP correlated with the number of transitional CD24+CD38+ B cells (p = 4.8 × 10−4) and circulating serum concentrations of Monocyte hemoattractant Protein (MCP)-2 (p = 3.6 × 10−4). We also found that the CD46rs1142469 SNP corre lated with numbers of CD19+ B cells, CD19+CD3− B cells, CD5+ IgD− cells, IgM− cells, IgD−IgM− cells, and CD4−CD8− PBMCs (p = 4.9 × 10−4−8.6 × 10−4 ) and circulating concentrations of interleukin (IL)-20 (p = 0.00082). Finally, we observed that the CDKN2Ars2811710 SNP correlated with levels of CD4+EMCD45RO+CD27− cells (p = 9.3 × 10−4 ). These results suggest that genetic variants within these six loci influence MM risk through the modulation of specific subsets of immune cells, as well as vitamin D3−, MCP-2−, and IL20-dependent pathways.This work was supported by the European Union’s Horizon 2020 research and innovation program, N° 856620 and by grants from the Instituto de Salud Carlos III and FEDER (Madrid, Spain; PI17/02256 and PI20/01845), Consejería de Transformación Económica, Industria, Conocimiento y Universidades and FEDER (PY20/01282), from the CRIS foundation against cancer, from the Cancer Network of Excellence (RD12/10 Red de Cáncer), from the Dietmar Hopp Foundation and the German Ministry of Education and Science (BMBF: CLIOMMICS [01ZX1309]), and from National Cancer Institute of the National Institutes of Health under award numbers: R01CA186646, U01CA249955 (EEB).This work was also funded d by Portuguese National funds, through the Foundation for Science and Technology (FCT)—project UIDB/50026/2020 and UIDP/50026/2020 and by the project NORTE-01-0145-FEDER-000055, supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF)

La participación ciudadana en el ámbito local de la Región de Murcia (2010-2020)

Esta tesis doctoral tiene como objetivo analizar los diferentes elementos que motivan la participación ciudadana en los municipios de la Región de Murcia. Se ha llevado a cabo a través del análisis de los múltiples factores que influyen en las distintas experiencias de intervención de la ciudadanía en la gestión pública local. El análisis de las dificultades deja entrever como la propia estructura administrativa, la falta de motivación de la ciudadanía o la debilidad del tejido asociativo que no se adapta a los procesos de digitalización de la sociedad, son parte del problema. Se suman la ausencia de consensos políticos, la falta de voluntad política de los actores que participan, y el alto esfuerzo que exige mantenerse en los procesos y en las relaciones con el poder, de ahí que la formación de redes de dependencia clientelar se convierta en uno de los riesgos limitantes para el desarrollo de la participación ciudadana.This doctoral thesis studies the different elements that motivate the citizen participation in the municipalities of the Region of Murcia. This goal has been achieved by means of the analysis of numerous factors that influence the different experiences of citizen intervention in local public management. The analysis demonstrates that administrative structure, lack of citizen motivation or weakness of associative network not adapted to digitization processes are part of the problem. Political consensus, lack of political will of actors, and high effort required to remain in power relations can be added. Hence, the formation of patronage dependency networks become one of the limiting risks for the development of citizen participation

Styles of substance use by gender. An approach from speech analysis

The intention with this article is to shed light on the different characteristics in the consumption of addictive substances considering gender, in order to provide the tools and instruments which are essential to the design of programs and treatments that incorporate that perspective in their daily practice. The final aim is that these treatments are of greater efficiency, both in access/joining these women with addictions, and the outcome of rehabilitation. It is, thus, to acquire more knowledge to better use of resources and services that are operated reintegration of addicts both private and public partnerships.Differences socially assigned to each gender inequalities produced an impairment affecting the health, development and welfare of women relative to men. Through qualitative methods (interviews and focus groups), it has been evident from the analysis of discourse, how women consume, what kind of substances are more associations, social charges in addition to being a woman addicted (multiple discrimination) and difficulties show themselves when accessing drug treatment.\ua